Discover why Exact Sciences, a leading oncology diagnostics company, may see growth in the cancer diagnostics market with its ...

Exact Sciences Corp (EXAS) stock saw a modest uptick, ending the day at $55.98 which represents a slight increase of $0.85 or 1.54% from the prior close of $55.13. The stock opened at $54.84 and ...

For every birdie made on the 15th hole, the Cologuard Classic by Exact Sciences will donate $1,500 to pay for a cancer ...

We recently published a list of 10 Companies Reflect Market Decline. In this article, we are going to take a look at where ...

The US company said that results from the Alpha-CORRECT trial saw its colon cancer diagnostic Oncodetect achieving a ...

Exact Sciences stock crumbled Thursday — extending its losses this week — on its growing rivalry with Guardant Health and Natera in colon cancer screening. Please watch the video at Investors ...

One of the 30-second spots taps into the intensity of hit shows like “Game of Thrones.” It starts with a medieval royal preparing to go to war in the name of colorectal cancer screening, declaring, ...

MADISON, Wis., January 21, 2025--Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, will present 11 abstracts at the American Society of Clinical ...

EXACT Sciences Corp. is a molecular diagnostics company, which focuses on the early detection and prevention of colorectal cancer. It developed Cologuard, a screening test for the early detection ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...